BiomeMimetics invites every customer to participate in our community-driven product trials. This collaborative process shapes highly refined solutions that genuinely reflect your customers' needs, advancing wellness science for everyone.
STUDY 1:
Now Recruiting: Clinical Study on ACEND™ for Dietary Management of gastrointestinal
discomfort in adults with IBS or SIBO
BiomeMimetics is currently recruiting participants for a clinical study evaluating ACEND™, a novel medical food designed for the dietary management of chronic inflammation. This 3-month study is open to adults aged 18–50 who have been diagnosed with IBS (Irritable Bowel Syndrome) or SIBO (Small Intestinal Bacterial Overgrowth) and experience symptoms such as bloating, abdominal discomfort, or irregular bowel habits. Participants will consume ACEND™ twice daily and track their health through an interactive daily in-app survey, providing real-time insights into their progress. This research supports our mission to develop microbiome- informed interventions that restore balance and improve quality of life.
STUDY 2:
Now Recruiting: Clinical Study of ACEND™ for Joint Health and Osteoarthritis Relief
BiomeMimetics is enrolling participants for a 3-month clinical study evaluating ACEND™, a novel medical food designed for the dietary management of chronic inflammation in adults with early-stage osteoarthritis. Individuals aged 40–60 experiencing joint pain, stiffness, swelling, or tenderness may be eligible. The study involves taking ACEND™ twice daily and tracking outcomes through a daily survey using a personalized health app. This research supports our commitment to advancing microbiome-targeted solutions for inflammatory conditions.
STUDY 3:
Now Recruiting: Clinical Study of ACEND™ for Chronic Back Pain
BiomeMimetics is conducting a 3-month clinical study evaluating ACEND™, a microbiome-focused medical food developed to support the dietary management of inflammation and musculoskeletal health.The study is enrolling adults aged 30–75 with a diagnosis of chronic low back pain—defined as pain lasting longer than 3 months—who are not currently on opioid medications or enrolled in other investigational treatment programs. The study involves taking ACEND™ twice daily and tracking outcomes through a daily survey using a personalized health app. This research supports our commitment to advancing microbiome-targeted solutions for inflammatory conditions.
PARTNER
